ELAN Q4 2021 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

Q4 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B-2.3% YoY

Gross Profit

$462M41.5% margin

Operating Income

$43M3.9% margin

Net Income

-$104M-9.3% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

-1.6%

Cash Flow

Operating Cash Flow

$223M

Free Cash Flow

$132M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$16.5B

Total Liabilities

$9.0B

Stockholders' Equity

$7.5B

Cash & Equivalents

$638M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.1B	-2.3%
Gross Profit	$462M	$380M	+21.6%
Operating Income	$43M	-$107M	+140.2%
Net Income	-$104M	-$323M	+67.8%

Revenue Segments

Farm Animal

$604M54%

Pet Health

$494M44%

Contract Manufacturing

$15M1%

Geographic Segments

Non-US

$610M55%

UNITED STATES

$503M45%